News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis AG (NVS) Recalls 5.3 Million Bottles Of BP Meds Due To Packaging Glitch



12/23/2013 8:05:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Here is a headache no drugmaker wants to endure. Last July, Novartis began recalling a few million bottles of samples of different medicines that were distributed to physicians, because routine testing determined that a chemical used in shrink wrap packaging was found to leech into some tablets. The incident appears to be an unusual instance in which samples given to doctors have been yanked. The voluntary recall amounted to 127 lots of samples for three blood pressure treatments - Exforge, Tekturna and Diovan – as well as the Lescol cholesterol pill and the Stalevo Parkinson’s drug, although a Novartis spokeswoman was unable to say many bottles were involved in the recall, although The Wall Street Journal reported about 5.3 million bottles were involved.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES